Alignment Healthcare (ALHC, $6.29) was a top weekly gainer, with a +18.23% jump
Alignment Healthcare (ALHC) had an impressive week, gaining over 18% to close at $6.29 per share. This strong upward movement was not limited to ALHC alone, as A.I.dvisor's analysis showed that all 16 stocks in the Managed Health Care Industry trended upwards, indicating a positive trend for the entire sector.
Looking specifically at ALHC's technical indicators, the Relative Strength Index (RSI) Oscillator is worth noting. The RSI moved out of oversold territory on April 24, which suggests a potential shift in the stock's trend from downward to upward. Traders may want to consider buying the stock or call options.
To gain a deeper understanding of the implications of this indicator, A.I.dvisor examined 15 similar instances where the RSI Oscillator left oversold territory, finding that in 12 of those cases, the stock moved higher. This gives a probability of 80% that ALHC's stock will continue to trend upward.
While technical indicators like the RSI Oscillator can provide valuable insights for traders, it's important to consider other factors as well, such as the company's financial performance. In this regard, ALHC's most recent earnings report shows promising signs.
For the fourth quarter of 2022, ALHC reported $294 million in revenue, a 34% increase from the previous year. The company's net income also saw a significant improvement, with a $9.8 million profit compared to a $15.1 million loss in the same period last year. These results suggest that the company is making positive strides towards profitability.
Furthermore, ALHC's outlook for the future is optimistic, with the company forecasting continued revenue growth in the range of 20-25% for the next fiscal year. This projection is supported by the company's recent expansion efforts, such as its acquisition of a Medicare Advantage plan in Texas.
ALHC's impressive performance this week, combined with a positive technical indicator and promising earnings report, make it an intriguing prospect for traders and investors alike. However, as with any investment, it's important to conduct thorough research and consider all relevant factors before making any decisions.
ALHC's RSI Oscillator ascending out of oversold territory
The RSI Indicator for ALHC moved out of oversold territory on May 31, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In of the 17 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 07, 2023. You may want to consider a long position or call options on ALHC as a result. In of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ALHC just turned positive on June 07, 2023. Looking at past instances where ALHC's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .
ALHC moved above its 50-day moving average on June 06, 2023 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALHC advanced for three days, in of 123 cases, the price rose further within the following month. The odds of a continued upward trend are .
ALHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for ALHC crossed bearishly below the 50-day moving average on May 31, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ALHC entered a downward trend on June 07, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALHC's P/B Ratio (5.631) is slightly higher than the industry average of (2.801). ALHC's P/E Ratio (0.000) is considerably lower than the industry average of (19.008). ALHC's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.199). ALHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.795) is also within normal values, averaging (0.712).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
Industry ManagedHealthCare
ALHC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALHC has been loosely correlated with BHG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALHC jumps, then BHG could also see price increases.
| Ticker / NAME | Correlation To ALHC | 1D Price Change % | ||
|---|---|---|---|---|
| ALHC | 100% | +1.37% | ||
| BHG - ALHC | 46% Loosely correlated | +0.19% | ||
| CLOV - ALHC | 45% Loosely correlated | -2.91% | ||
| OSCR - ALHC | 32% Poorly correlated | +0.17% | ||
| ELV - ALHC | 29% Poorly correlated | -0.99% | ||
| CNC - ALHC | 28% Poorly correlated | +1.45% | ||
More | ||||
